441 filings
Page 9 of 23
6-K
CLLS
Cellectis
9 Apr 21
Cellectis Completes Sale of $47 million through its ATM Program
6:17am
6-K
CLLS
Cellectis
29 Mar 21
Current report (foreign)
4:55pm
6-K
CLLS
Cellectis
29 Mar 21
Current report (foreign)
4:38pm
424B5
CLLS
Cellectis
29 Mar 21
Prospectus supplement for primary offering
4:35pm
S-8 POS
CLLS
Cellectis
4 Mar 21
Registration of securities for employees (post-effective amendment)
5:13pm
20-F
2020 FY
CLLS
Cellectis
Annual report (foreign)
4 Mar 21
4:51pm
6-K
CLLS
Cellectis
4 Mar 21
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results
4:48pm
6-K
CLLS
Cellectis
19 Feb 21
Calyxt Announces Dr. Yves Ribeill Appointed As Executive Chair Replacing
5:17pm
SC 13G/A
CLLS
Cellectis
16 Feb 21
Cellectis / Capital International Investors ownership change
3:58pm
6-K
CLLS
Cellectis
16 Feb 21
Cytovia Therapeutics and Cellectis Partner to Develop TALEN® Gene-Edited iPSC-Derived Natural Killer Cells
6:10am
SC 13G/A
ARK Investment Management LLC
16 Feb 21
Cellectis / ARK Investment Management ownership change
12:00am
SC 13D/A
CLLS
Cellectis
12 Feb 21
Cellectis / Bpifrance Participations ownership change
2:09pm
SC 13G/A
CLLS
Cellectis
8 Feb 21
Cellectis / FMR ownership change
10:17am
CT ORDER
CLLS
Cellectis
29 Dec 20
Confidential treatment order
8:53am
6-K
CLLS
Cellectis
29 Dec 20
Current report (foreign)
7:48am
6-K
CLLS
Cellectis
16 Dec 20
Cellectis Announces Withdrawal of Follow-On Offering
3:00pm
424B5
CLLS
Cellectis
14 Dec 20
Prospectus supplement for primary offering
9:41pm
FWP
CLLS
Cellectis
14 Dec 20
Free writing prospectus
5:12pm
6-K
CLLS
Cellectis
14 Dec 20
Cellectis Announces Launch of Follow-On Offering
4:30pm
6-K
CLLS
Cellectis
7 Dec 20
Current report (foreign)
6:06am